Twinbeech Capital LP Exelixis, Inc. Transaction History

Twinbeech Capital LP

$4.99 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $8.87 Million - $11.1 Million	-460,562 Reduced 94.05%	29,132 $698,000
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $2.35 Million - $2.81 Million	123,684 Added 33.79%	489,694 $10.7 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $3.93 Million - $4.43 Million	216,368 Added 144.59%	366,010 $6.99 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $4.64 Million - $5.52 Million	-284,438 Reduced 65.53%	149,642 $2.9 Million
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $3.56 Million - $4.13 Million	-237,709 Reduced 35.38%	434,080 $6.96 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $10.5 Million - $15 Million	671,789 New	671,789 $10.5 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $504,275 - $671,281	-29,611 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $559,104 - $772,298	-35,297 Reduced 54.38%	29,611 $541,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $93,024 - $120,645	-5,707 Reduced 8.08%	64,908 $1.37 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $520,819 - $741,623	29,015 Added 69.75%	70,615 $1.29 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $67,256 - $82,620	-3,276 Reduced 7.3%	41,600 $940,000
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $825,269 - $1.11 Million	44,876 New	44,876 $901,000
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $349,725 - $582,592	-21,247 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $136,010 - $205,050	9,406 Added 79.44%	21,247 $366,000
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $179,391 - $223,676	11,841 New	11,841 $209,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Account